Archive for the ‘Penny Stock Picks’ Category

Hampton Roads Bankshares, Inc. (NASDAQ:HMPR)

Tuesday, March 1st, 2011

I found a possible speculative play in the Penny Stock arena. I generally do not dabble with stocks under $1 billion market cap, but I couldn’t pass this up. What caught my attention was the recent insider transaction which is discussed below. In the interim let’s do our due diligence together about this company.

Hampton Roads Bankshares, Inc. (NASDAQ:HMPR) incorporated on February 28, 2001, primarily serves as a holding company for the Bank of Hampton Roads (BOHR). The Company engages in a general community and commercial banking business, emphasizing the needs of individuals, and small to medium-sized businesses in its primary service areas, which include South Hampton Roads, Virginia, the Northeastern, Southeastern and Research Triangle regions of North Carolina, the Eastern Shore of Virginia and Maryland, and Richmond, Virginia. The Company offers traditional loan and deposit banking services, as well as telephone banking, Internet banking, remote deposit capture, and debit cards. It accepts both commercial and consumer deposits. These deposits are in varied forms of both demand and time accounts including checking accounts, interest checking, money market accounts, savings accounts, certificates of deposit, and individual retirement (IRA) accounts. Additionally, it also offers a network of 72 automated teller machines (ATM) to support its customers.

BOHR is a Virginia state-chartered commercial bank with 28 full-service offices in the Hampton Roads region of southeastern Virginia, including 11 offices in the city of Chesapeake, five offices in the city of Norfolk, 10 offices in the city of Virginia Beach, and two offices in the city of Suffolk. In addition, BOHR has 24 full-service offices located in the Northeastern, Southeastern, and Research Triangle regions of North Carolina and in Richmond, Virginia that do business as Gateway. Through its acquisition of Gateway, the bank owns four wholly owned operating subsidiaries. Gateway Insurance Services, Inc., an insurance agency with offices in Edenton, Hertford, Elizabeth City, Plymouth, Moyock, and Kitty Hawk, North Carolina and the Hampton Roads area of Virginia, sells insurance products to businesses and individuals. Gateway Investment Services, Inc. assists Gateway customers in their securities brokerage activities through an arrangement with an unaffiliated broker-dealer. Gateway Bank Mortgage, Inc. provides mortgage banking services with products that are sold on the secondary market. Gateway Title Agency, Inc. engages in title insurance and settlement services for real estate transactions.

The Company offers a range of commercial, real estate and consumer lending products and services. Its loan portfolio is include commercial, construction, real estate-commercial mortgage, real estate-residential mortgage, and installment loans to individuals. Commercial loans are made to businesses which are not collateralized by real estate. The purpose of commercial loans is for the financing of accounts receivable, inventory, or equipment and machinery. Construction and development loans are made to individuals and businesses for the purpose of construction of single family residential properties, multi-family properties, and commercial projects, as well as the development of residential neighborhoods and commercial office parks. The Banks make commercial mortgage loans for the purchase and re-financing of owner occupied commercial properties, as well as non-owner occupied income producing properties. These loans are secured by various types of commercial real estate including office, retail, warehouse, industrial, storage facilities, and other non-residential types of properties.

Current market cap at today’s close of $1.02 is just shy of $700 million with an average daily volume of 712k; Hampton Roads Bankshares (NASDAQ:HMPR) has a price to book ratio of 4.1x based on a current price of $1.02 and a book value per share of $0.28. 680 million shares are outstanding with 1.7million shares short at a 3.57 ratio. Q4 2010 Earnings are to be released Mar 9, 2011. This may be the only thing holding me back on taking a large position. Judging from prior Q3 earnings, which I must admit is an eyesore reports Sept Q3 NetProfit Loss of -353%

The only positive thats captured my attention is below insider buys and the fact the price sits just above the 200 day MA. We’ll have to wait and see where this stock is heading. See below trends.

On May 24, 2010 Carlyle Group and Anchorage Advisors announced that it had made a participating investment of $275 million in capital for Hampton Roads Bankshares, Inc.(HMPR), a Virginia based regional bank.  Carlyle and Anchorage will each acquire at least 168.8 million shares for about $72.6 million, or 26% of the company’s voting equity.

Largest Holders believe it or not just filed to purchase $14 & $10 million dollars worth respectively on 12/28/2010. Click below filings

Acmo, Hr L L C

 Beneficial Owners – 179,850,000
Goldstein, Robert B Directors – 151,043,000

Tags: , , , , , ,
Posted in Contributors, Penny Stock Picks | No Comments »

CROSSWIND RENEWABLE ENGY (PINK: CWNR) Continues To Move Higher

Monday, January 24th, 2011

Shares of CROSSWIND RENEWABLE ENGY (PINK:CWNR) jumped once again on Tuesday after it announced 10 year Marketing Agreement with Stanlin Energy Corp.

Under the Agreement, CROSSWIND RENEWABLE would take the responsibility to market, sell and install Stanlin Energy’s flue draft control device. Under the terms of the Agreement Crosswind receives rights to the exclusive use of the Crosswind Renewable Energy Brand.

Shares of CWNR soared 56.50% on Tuesday and over the past one week, the stock has skyrocketed over 186%.

The stock had started moving higher after on Jan 11, it announced a multi year Sole Distributor Agreement with Intermountain Wind and Solar.

Headquartered in Naples, Florida, Crosswind Renewable Energy is a Clean Energy Solutions Company and a Global Provider of category leading Renewable Energy Technology.

Tags: , , ,
Posted in Penny Stock Picks, Stocks | No Comments »

UNLA soared On LOI

Sunday, January 23rd, 2011

Unilava Corporation. (OTC:UNLA) Shares climbed on Tuesday after the company reached a letter of Intent with china based high speed broadband provider China Wi-MAX Communications, Inc..

The company confirms agreement to joint venture with China Wi-MAX and Unilava Corporation and its affiliates in China. Both the companies are on the way to form a joint Alliance which would help sharing operational resources, including fiber, wireless networks and data centers.

That being said, Unilava Corporation would be able to expand its footprint in China which will bring industry-leading port access, increased deployment flexibility and new residential and business solutions to the Unilava Corporation portfolio.

Shares of UNLA soared 54.55% to $0.0850 on over 1.70 million shares, compared to its average volume of 166K shares.

Unilava Corporation (Unilava), formerly IWI Holding Limited, is a diversified communications holding company. Unilava, with its operations primarily conducted by its subsidiaries, provides a variety of communications services, products, and equipment that address the needs of small to enterprise businesses and consumers.

Tags: , , ,
Posted in Penny Stock Picks, Stocks | No Comments »

HNHI Up 290%; Markets Finish Off Lows

Monday, January 10th, 2011

U.S. stocks on Monday ended lower as investors took a wait-and-see approach ahead of the unofficial kickoff of earnings season after the close. Marking its third straight session of declines, the DJIA fell 37.31 points, or 0.3%, to 11,637.45.

All in all it’s sort of a mixed day given the tragic events over the weekend and the fact that there is no economic data to guide the market. Markets I believe are due for a pull back especially with the noise getting louder and louder with the ECB and Portugal. It’s a matter of time Portugal will forced upon the hand it feeds.

The whole earnings season kicking off tonight is another reason nobody is making big bets right now. After the bell, Aluminum maker Alcoa reported a fourth-quarter profit of $258 million, or 24 cents a share, topping Wall Street estimates.

Off the blue-chip index, Duke Energy Corp. (DUK 17.57)   said it would buy Progress Energy Inc. (PGN 43.62)  for $13.7 billion in stock.

On the New York Mercantile Exchange, benchmark oil for February delivery topped $89 a barrel. See more on Alaskan pipeline interruption and the fallout for crude futures.

On Wednesday, Portugal is scheduled to conduct a bond auction, with Spain and Italy expected to follow suit Thursday. Finance ministers of the European Union are scheduled to meet next Monday in Brussels. I would say Europe’s problems are still closely watched on this side of the pond but for right now, it’s not making too big waves.

Other news:

HNHI: Annoucement from this morning finished 290% on 9 million in volume currently priced at $ .39. Congratulations!!!

Tags: , , , , ,
Posted in Contributors, Penny Stock Picks, Stock Market News | No Comments »

H & H Imports Inc.- HNHI & 50 Cent Rapper

Monday, January 10th, 2011

Curtis J. Jackson aka. 50 Cent and his company G-Unit Brands has acquired 30 million shares of (HNHI) H & H Imports Inc.

According to data from the Consumer Electronics Assn., the market for headphones spiked from 59 million units sold and $490 million in revenue at the end of 2008-the year Beats by Dre launched-to 68.7 million units sold and revenue of $648 million the following year. For 2010, the CEA expects a slight increase to 70.8 million units sold with $670 million in revenue, forecast to grow incrementally next year to 73.6 million units sold and $681 million in revenue. HNHI company that has just acquired worldwide marketing rights to a new line of Sleek Wireless Hybrid and Tunable audio products that will be personally endorsed by Curtis Jackson, p/k/a “50 Cent!” 50 Cent, through G-Unit, a company owned by Jackson, has an ownership interest in Sleek. Under its Agreement with Sleek and G-Unit, TV Goods also made an equity investment in Sleek. 50 Cent, through G-Unit, has also made an equity investment in TV Goods, which makes him a significant minority shareholder in TV Goods and will be offered a seat on the Board of the Company at a later date! As part of the marketing campaign, 50 Cent will be actively endorsing and promoting the Platinum line of Wireless Hybrid Sleek by 50 Cent(TM) products at concerts, in music videos, retail packaging, point-of-purchase videos, live appearances (including national and international live shopping networks), at the 2011 CES Show in Las Vegas, and other venues, on a worldwide basis.

50 Cent will be touring in Europe beginning February 2011 and will be tying in appearances in support of the product during his tours. Sleek also plans to launch a contest involving 50 Cent and the products.

TV Goods Chairman, Kevin Harrington, said, “When we initially heard Sleek Audio was teaming with 50 Cent we knew it was a partnership we wanted to become a big part of. We’re always looking for products that set the standard, bringing new concepts to market that consumers understand, appreciate and desire. With our knowledge of the retail market, 50′s vision and celebrity, and most importantly Sleek Audio’s innovative product designs, this team we’ve put together is set to deliver some truly exciting products to the market.”

50 Cent stated, “I know music, and I’ve tried everything on the market as far as headphones go, but I wanted something different, something better, that really pushed the envelope and gave my fans, and all music fans, a new way to listen to their favorite artists. I was fortunate to find Sleek. The technology they employ and their knowledge of how we hear truly blew me away. It was a perfect match. I didn’t want to just create another pair of loud headphones; I wanted to create headphones that offer top-level performance, style and new technology. Teaming up with Kevin Harrington and TV Goods as our exclusive marketer/distributor will enable us to go head to head with market leaders and beat them in the battle for the hearts, minds and heads of music listeners everywhere.”

Mark Krywko, President and CEO of Sleek, said, “We are excited at the opportunity to work with the world’s most toured artist. The key to creating this relationship was bringing 50 and TV Goods into the Sleek family and vice versa. He’s not just slapping his name on the side of a product, he’s part owner of both companies and an integral part of what we’re doing. By combining our knowledge of acoustics and hearing aid science with 50′s experience as a recording artist, we’ve created something that music lovers of all genres are really going to love, and something TV Goods can drive sales for on a worldwide basis.”

G-Unit Brand’s (owned by 50 Cent) actual ownership in HNHI is 7.5 million shares that it purchased in a private placement at $0.10, HNHI‘s current share price. The rest of the 30 million is warrants. G-Unit Brands has warrants to purchase 7.5 million shares at $0.15, 7.5 million shares at $0.25, and 7.5 million shares at you guessed it… $0.50!  So right now at $0.10, you can get in at the same price 50 Cent did!According to Billboard magazine, as of November Beats by Dre was on track to sell 1.3 million units in 2010. With the average Beats by Dre headphones set costing around $300, we can estimate that Beats by Dre generated revenues last year of $390 million.

HNHI‘s current market cap at $0.10 is only around $20 million

Tags: , , , , ,
Posted in Contributors, Penny Stock Picks | No Comments »

Advanced Cell Technology – ACTC; FDA Approves Trial

Tuesday, January 4th, 2011
I like to forward an article that a colleague had brought to my attention – A report by CNN Health Section. Link provided here
CNBC report provided here as well. I truly believe this is an earth shattering news. Volume in ACTC sure has grabbed investors attention. It’s currently down 14% but has made a huge run-up in the last month. It’s due for a correction, but none-the-less this is a buy-out candidate in my opinion.
 
FDA approves second human embryonic stem cell trial

For only the second time in history, the Food and Drug Administration has approved human trial of a therapy developed from embryonic stem cells.

William Caldwell, CEO of Massachusetts-based Advanced Cell Technology (ACT), tells CNN that 366 days after filing the application, the FDA granted approval for his company to start a clinical trial using cells grown from human embryonic stem cells.  The treatment will be for an inherited degenerative eye disease.

“Were still absorbing the fact that we finally got the approval” says Caldwell.  “The real work lies ahead.”  Getting the trial going is the next big step, says Caldwell.  He hopes the first patients can be enrolled by the first quarter of the next year.

In July the FDA gave the Geron Corporation the final go-ahead for its study, which led to the first human being injected with cells derived from human embryonic stems last month. In that study a newly paralyzed patient had a stem cell treatment directly injected into the spinal cord. While the immediate goal is to test the safety of these cells, the ultimate goal in Geron’s trial is to permanently repair damage cause by a spinal cord injury.

When ACT’s clinical trial gets under way, it,too, will first test the safety of the cells they’re injecting.  The company is hoping to find a cure for Stargardt Macular Dystrophy, the most common form of juvenile macular degeneration, for which there is currently no cure.  It affects about 1 in 10,000 children. People with this disease usually start losing their sight between the ages of 8 to 10 years and can be legally blind by the time they reach their 30s says Caldwell.

Embryonic stem cells are only four to five days old and have the ability to turn into any cell in the body.  But the cells patients will receive in both of these clinical trials aren’t pure human embryonic stem cells.  Geron has coaxed its cells into becoming a type of cell that insulates nerve cells.  ACT’s stem cells have been turned into healthy retinal pigment epithelium (RPE) cells.   RPE cells are naturally found behind the neural retina and it’s the death of these cells that leads to blindness in patients with macular degeneration.  The company says their animal studies found vision restored after these new RPE cells were injected.

If this treatment works, Caldwell believes it could be applied to other diseases that lead to blindness, including age-related macular degeneration, which affects millions of Americans and will only increase as baby boomers continue to get older.

ACT’s  method of removing stem cells from an embryo is different from Geron’s. ACT developed a method in which only one stem cell is removed from an embryo, similar to a method  used in some fertility clinics to test an embryo for genetic abnormalities.  That stem cell is then used to grow many more stem cells.  By removing only one stem cell, the embryo is not destroyed. Destruction of embryos  is the main reason that embryonic stem cell research has been so controversial.

Tags: , , , , , ,
Posted in Contributors, Penny Stock Picks | No Comments »

Supatcha Resources Inc (OTC: SAEIE) Climbs New High after Unsolicited Bid from OXM

Sunday, December 12th, 2010

Shares of Supatcha Resources Inc (OTC:SAEIE) climbs 77.47% to trade close at $0.70 from its previous close of $0.40. The stock traded in the range of $0.25 to $0.93 in its last trading session & has 52 week range of $0.03 to $0.93.

On Dec 10, the company said that it received an offer from OXM Group (OXM) to purchase it through an unsolicited bid where all the issued and outstanding shares of the company will be purchased at a price of $1.75 per share.

On Dec 9, the company announced the results of the first NI 43-101 compliant resource estimate for the Barlevskoye and Vynohradiv Gold Property after receiving all necessary paperwork in order to file the NI 43-101 technical report for the above gold projects on Dec 7.

The Company also announced on Dec 7, that it has signed a definitive agreement and acquired a 50% vested title interest in advanced staged Balka Skyrokaya gold property located in the Ukraine. As per this agreement, the company will pay a total of $2 million over 5 years to the owner of the property and will complete the work in 5 years by spending around $5 million. In the first year of work, it will spent $500,000 on the property. The company can also acquire a 90% interest in the property by paying an additional $1.5 million over 4 years and by completing an additional work in $3 million over 4 years after earning 50% interest.

The Company also said that after analyzing recent market activity, it can provide no explanation for the recent volatility in the trading of the Company’s shares.

Currently, the market capitalization of the stock stands at $42.76 million. The Stock made it new 52 week high on Friday and has 50 day & 200 day moving average of $0.24. 24.45 million shares have been traded in its last trading session, up from the daily average volume of 8.5 million shares.

Supatcha Resources Inc. is an exploration-stage company. The Company is engaged in the acquisition and exploration of mineral properties with a view to exploiting any mineral deposits it discovers, which demonstrate economic feasibility.

Tags:
Posted in Penny Stock Picks | No Comments »

ACTC jumps 21.5% on last week’s news

Tuesday, December 7th, 2010

Advanced Cell Technology, Inc. (OTC: ACTC) jumped 21.5% to trade close at $0.13 on no significant news of accord.

Shares of the Company gained $0.023 and closed at $0.13 after creating a new 52-week high of $0.14 on a high volume of 59.72 million shares as compared to its average trading volume of 12.28 million shares. The market capitalization of the Company stood at $141.47 million on 1.09 billion shares outstanding. At present ACTC’s shares are trading above the 50-Day Moving Average of $0.06 and 200-Day Moving Average of $0.07.

The Company had on December 1, 2010 announced the filing of an Investigational New Drug (IND) Application with the US Food and Drug Administration (FDA) for a clinical trial to treat patients with Dry Age-Related Macular Degeneration (Dry AMD) which will use human embryonic stem cell (hESC) derived retinal pigment epithelial (RPE) cells. This Phase I/II trial is an open-label study to determine the safety and tolerability of the RPE cells following sub-retinal transplantation to patients with Dry AMD.

ACTC had also on December 2, 2010 announced the elimination of approximately $3 million in debt over the past several weeks and thereby strengthening its balance sheet. The Company’s outstanding convertible debentures has reduced to approximately $890,000 after the conversion of senior and subordinated debentures to equity. Since September 2009, the Company has eliminated approximately $33 million in indebtedness.

Advanced Cell Technology, Inc. operates as a biotechnology company focused on development and commercialization of human embryonic and adult stem cell technology in the emerging field of regenerative medicine. The Company has acquired, developed and maintains a portfolio of patents and patent applications that forms the base for its research and development efforts in the area of embryonic and adult stem cell research.

Tags: , ,
Posted in Penny Stock Picks | No Comments »

Nano Cap Stock of the Week: Icagen, Inc. (NASDAQ: ICGN)

Monday, December 6th, 2010

Icagen, Inc. (NASDAQ:ICGN), the best-performing nano stock last week which surged 60.91% from $1.10 on Nov 29 to $1.47 on Dec 3. Year-to-date the stock went down by 51.05%. On Friday the stock traded in the range of $1.72 – $1.94 and has 52 week range of $0.93 – $9.60.

Shares of ICGN are currently above its 50 day & 200 day moving average of $1.31 & $2.33 respectively. The Company has total outstanding shares of 5.97 million, of which 3.82 million shares are floating. About 57.23% are held by insiders and 25.70% are held by institutions. Volume of 244,231 shares has been traded on the last trading session, down from daily average volume of 403,784 shares with market capital of $10.55 million

On Nov 30, the company announced an update on its sodium channel program for pain and related disorders, which is being conducted in collaboration with development partner Pfizer (NYSE: PFE). Both companies recently conducted a clinical study on healthy volunteers of several collaboration compounds targeting the sodium ion channel Nav1.7.  This news gained heavy investors interest on the stock.

ICGN also announced that it will receive a $1 million milestone payment from Pfizer related to the selection of the compound. It expects phase 1 trial will begin either this year or early in 2011. This trial might take 12 to 18 months, and Pfizer will pay the expenses for the trials, which is estimated to be in the range of $2 million.

For the third quarter 2010, the net loss reported was $239,000 as compared to a net loss of $3.5 million during the same period in 2009, a decrease of 93%. Net revenue at $4.5 million has been posted for the quarter as compared to $2.2 million for the previous year, a solid increase of 103%. The decrease in net loss was due to increases in revenue and reduced operating expenses. The increase in revenues was due primarily to the $3.0 million of milestone revenue earned during the period from the Pfizer collaboration.

Icagen, Inc. (Icagen) is a biopharmaceutical company focused on the discovery, development and commercialization of orally-administered small molecule drugs that modulate ion channel targets.

Tags: , ,
Posted in Penny Stock Picks, Stocks | No Comments »

Double-Digit PINK Stock Movers Of The Day (SNMN, ENTI, QMIN)

Tuesday, November 30th, 2010

SNM Global Holdings (PINK: SNMN) skyrocketed 200% to $0.0003 on about 433.35 million shares. The company announced it signed a Letter of Intent to acquire 51% of Banx and Green Group Inc. Banx and Green Group is an Alternative Energy Company with specialties in Green Construction and Biofuel Development and has a contract to build a minimum of 11 Emergi-Care centers with an estimated value of $28.6 million.

SNM Global Holdings, formerly CineMaya Media Group, Inc., and its subsidiaries are engaged in the entertainment, marketing and ethnic media landscape in North America and have a vertically integrated business model targeting the South Asian and Indian populations in North America.

Encounter Technologies Inc. (PINK: ENTI) slumped 22.22% to $0.0007 on over 161.96 million shares.

Entertainment Cruises International, Inc., formerly known as Encounter.com, Inc., is in the business of providing Internet products and services including, Internet access, colocation and professional services. The Company has formed a subsidiary, CyberCastingCorp.com, to grow externally by acquiring small Internet service providers marketing a wide range of Internet products and services.

Kentucky Energy, Inc. (PINK: QMIN) is 100% higher at $0.0004. The company announced the financial results for September 30, 2010.

The Company incurred an operation loss of $344,943 for the three months ended September 30, 2010, compared to an operating loss of $615,843 for the three months ended September 30, 2009.

For the third quarter, the Company’s coal revenues were $764,841 for the three months ended September 30, 2010, as compared to $348,334 for the three months ended September 30, 2009, an increase of 125%.

Tags: , ,
Posted in Penny Stock Picks | No Comments »